Related Experiment Video
Updated: Jul 9, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
[Postoperative Management for Severe Pulmonary Hypertension Associated with Congenital Heart Disease]
11st Department of Surgery, University of Toyama, Toyama, Japan.
Abstract:
Preoperative and postoperative management in patients with pulmonary hypertension associated with congenital heart disease is improving by understanding of pathophysiology of pulmonary arterial hypertension (PAH) and several types of pulmonary vasodilators. While the irreversible PAH in untreated lesions has become rare in Japan, persisting/progressive PAH even after timely surgery remain challenging. To optimize preoperative and postoperative management in patients with PAH associated with congenital heart disease, adequate indication and treatment algorithms should be constructed.
More Related Videos
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumothorax-II
Clinical Manifestations:

